Key infiltrating immune populations include CD8+ T cells, CD4+ T cell subsets (Th1/Th2/Th17), natural killer (NK) cells, macrophages, and dendritic cells, collectively forming a dynamic immune network that governs tumor progression and therapeutic responses (13). Here, CD8A is linked to neoplasm.